Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Medicare May Soon Cover Ozempic, Wegovy
Biden wants Medicare, Medicaid to cover pricey weight loss drugs such as Wegovy
The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.
Biden wants drugs like Wegovy, Ozempic covered by Medicare, Medicaid
Millions of Americans with obesity would be eligible to have popular weight-loss drugs like Wegovy or Ozempic covered by Medicare and Medicaid under a new rule the Biden administration proposed Tuesday morning.
Medicare May Soon Cover Ozempic, Wegovy Under New Biden Proposal
If the proposal is finalized, it could set the stage for a showdown between the pharmaceutical industry and the Trump administration.
1h
on MSN
Medicare Could Pay for Wegovy. Don’t Count On It.
The Biden administration said it would allow the program to pay for GLP-1 anti-obesity drugs, but the Trump administration ...
HuffPost
8h
Biden Proposes Medicare And Medicaid Cover Weight-Loss Drugs For Obese Americans
WASHINGTON (AP) — Millions of Americans with obesity would be eligible to have popular weight-loss drugs like
Wegovy
or ...
Newsday
5h
Wegovy, Mounjaro: Suffolk County among employers rethinking access to costly weight loss drugs
Without insurance, one month of Ozempic can cost about $936;
Wegovy
, $1,349 and Mounjaro $1,023 in the U.S., according to a ...
The Hill
2h
Biden proposes Medicare, Medicaid coverage of obesity drugs
The Biden administration proposed a new rule Tuesday that would allow anti-obesity drugs like
Wegovy
and Zepbound to be ...
Opinion
1h
Opinion
The Case for Getting the Government to Pay for Wegovy
The Biden administration’s proposal to expand coverage of weight-loss drugs to Medicare and Medicaid recipients is expensive ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Joe Biden
Ozempic
United States Department of Health and Human Services
Feedback